TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06714253: Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1

Sponsor: RiboX Therapeutics Ltd. · Phase: PHASE1/PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 42 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$761,940

Rescue Site Savings

+$507,960

Unlock Full NCT06714253 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06714253 Rescue Dossier →